PolyNovo Limited posts first-half sales growth of 319%

PolyNovo Limited (ASX: PNV) is a biotechnology company which treats wounds using its polymer technology NovoSorb.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The PolyNovo Limited (ASX: PNV) share price has remained flat on Monday as it announced its sales of NovoSorb BTM for the first half of the 2019 financial year of $3.75m. This is a 319% increase on the prior corresponding period.

With a market capitalisation of around $392 million, PolyNovo develops medical devices using its patented polymer technology. NovoSorb Biodegradable Temporising Matrix (BTM) technology can be used to close wounds incurred through trauma, burns, surgery or wounding. The claim is that NovoSorb provides better results than rival products or skin grafts.

PolyNovo restructured in 2014 and has since made NovoSorb its main focus. The technology has gradually been proving itself as sales have picked up and results have been positive. Today's update affirms this thesis but may have been expected by the market, as the share price closed down 0.83% at 60 cents.

It's worth noting that PolyNovo isn't making a profit. While it incurred a $6.1m loss in the 2018 financial year, it also had 59% revenue growth. Biotechnology companies generally don't make a profit until their product is properly commercialised, which PolyNovo is still in the process of.

PolyNovo shares have risen 10.2% in the last 12 months, compared to a return of -7.17% for the S&P ASX/200.

Motley Fool contributor Cale Kalinowski has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Woman holding gold bar and cheering.
Gold

Why Macquarie expects this surging ASX 200 gold stock could leap another 40%

Macquarie forecasts another year of strong outperformance from this fast-rising ASX 200 gold miner.

Read more »

A young woman looks at here phone as she strides out in an airport dragging her wheelie bag behind her and smiling widely.
Broker Notes

Macquarie tips 15% upside for this ASX 200 industrials stock

Is this transportation business preparing for take-off?

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Record Highs

Big ASX 200 news! Market hits 8,700-point record high

It's a historic day for the ASX.

Read more »